Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics... Show more
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ALNY advanced for three days, in of 307 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ALNY's RSI Indicator exited the oversold zone, of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where ALNY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on November 13, 2025. You may want to consider a long position or call options on ALNY as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
ALNY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 226 cases where ALNY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Moving Average Convergence Divergence Histogram (MACD) for ALNY turned negative on October 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .
ALNY moved below its 50-day moving average on October 30, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ALNY crossed bearishly below the 50-day moving average on November 04, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALNY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALNY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ALNY's P/B Ratio (256.410) is slightly higher than the industry average of (24.460). ALNY's P/E Ratio (1513.233) is considerably higher than the industry average of (62.829). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.004). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (18.797) is also within normal values, averaging (339.020).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
a developer of therapeutics based on RNA interference
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SKOR | 49.07 | -0.08 | -0.16% |
| FlexShares Credit-Scored US Corp Bd ETF | |||
| BBIB | 99.62 | -0.15 | -0.16% |
| JPMorgan BetaBuilders U.S.TrsBd3-10YrETF | |||
| FB | 41.73 | -0.22 | -0.52% |
| Proshares S&P 500 Dynamic Buffer ETF | |||
| IJJ | 127.80 | -1.86 | -1.43% |
| iShares S&P Mid-Cap 400 Value ETF | |||
| STXG | 50.24 | -1.00 | -1.95% |
| Strive 1000 Growth ETF | |||
A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with ARGX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then ARGX could also see price increases.
| Ticker / NAME | Correlation To ALNY | 1D Price Change % | ||
|---|---|---|---|---|
| ALNY | 100% | +0.27% | ||
| ARGX - ALNY | 54% Loosely correlated | +0.21% | ||
| IONS - ALNY | 43% Loosely correlated | -3.89% | ||
| SGMO - ALNY | 42% Loosely correlated | -4.43% | ||
| BBIO - ALNY | 38% Loosely correlated | -1.75% | ||
| INSM - ALNY | 37% Loosely correlated | -1.76% | ||
More | ||||